Back

Integration of a Molecular Prognostic Classifier into the Ninth Edition TNM Staging of Lung Adenocarcinoma

2026-02-18 oncology Title + abstract only
View on medRxiv
Show abstract

IntroductionDespite advancements in non-small cell lung cancer (NSCLC) management through the use of molecular biomarkers, the recently introduced 9th edition of the TNM staging system remains based exclusively on anatomic descriptors, with no consistently demonstrated improvement in risk stratification for early-stage disease. This study explores the integration of a molecular prognostic classifier into the conventional TNM staging system. MethodsWe analyzed 502 patients with stage I-III lung ...

Predicted journal destinations